Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
HuHuangLianzonggan capsule
- Development stage
- Phase 2
- Lead developer
- Tasly Pharmaceutical
- Administration
- Oral
01
Overview
HuHuangLianzonggan capsule is an investigational botanical/herbal medicine developed by Tasly Pharmaceutical Group for the treatment of nonalcoholic steatohepatitis (NASH). As a traditional Chinese medicine (TCM) formulation, it is currently in Phase 2 clinical development. The drug is being evaluated in a randomized, double-blind, placebo-controlled, multi-center trial (HHL-HEPAR) to assess its efficacy and safety in subjects with biopsy-proven NASH, specifically targeting those with a NAFLD activity score (NAS) of 4 or higher and fibrosis stages 1 to 3. While the specific molecular targets and active chemical constituents have not been publicly disclosed, the treatment aims to improve liver histology and reduce steatohepatitis. It is administered orally in capsule form.
- Other names
- HuHuangLianzonggan
Beyond the preview
Go deeper on HuHuangLianzonggan capsule.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on HuHuangLianzonggan capsule.